Log In
Print
BCIQ
Print
Print this Print this
 

DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System

  Manage Alerts
Collapse Summary General Information
Company Elixir Medical Corp.
DescriptionPoly-L Lactide (PLLA)-based polymer coronary scaffold that delivers novolimus
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentMarketed
Standard Indication Cardiovascular (unspecified)
Indication DetailsTreat coronary artery disease (CAD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today